Clinical risk factors at 3 months of age for the development of bronchial asthma at 36 months of age
Pediatrics International · 2023
DOI: 10.1111/ped.15530 ↗At a glance
Journal article in Pediatrics International, 2023. Written by Shiro Sugiura and 7 co-authors. Institution: Department of Allergy, Allergy and Immunology Center, Aichi Children's Health and Medical Center, Aichi, Japan. Major MEDLINE topics: Asthma, Eczema. Cited 3 times so far (Crossref); 22 references.
Abstract (original language)
Background
We examined the associations between factors evident at the routine 3‐month well‐child visit (WCV) and the risk of developing 36‐month parent‐reported physician‐diagnosed bronchial asthma (BA).
Methods
This longitudinal study was conducted in Nagoya City, Japan, and included 40,242 children who qualified for the 3‐month WCVs in the city between April 1, 2016 and March 31, 2018. In total, 22,052 (54.8%) questionnaires linked to their 36‐month WCVs were analyzed.
Results
The prevalence of BA was 4.5%. The multivariable Poisson regression model identified male sex (adjusted risk ratio [aRR], 1.59; 95% confidence interval [CI]: 1.40–1.81), born in autumn (aRR, 1.30; 95% CI: 1.09–1.55), having at least one sibling (aRR, 1.31; 95% CI: 1.15–1.49), wheeze history before 3‐month WCVs, with clinic/hospital visit: aRR, 1.99; 95% CI: 1.53–2.56; hospitalization: aRR, 2.99; 95% CI: 2.09–4.12, eczema with itch (aRR, 1.51; 95% CI: 1.27–1.80), paternal history of BA (aRR, 1.98; 95% CI: 1.66–2.34), maternal history of BA (aRR, 2.11; 95% CI: 1.77–2.49), and rearing pets with fur (aRR, 1.35; 95% CI: 1.15–1.58) were independent risk factors for BA at 36 months of age. The combination of severe wheeze history (with clinic/hospital visit or hospitalization) and maternal and paternal BA could identify high‐risk infants whose prevalence of BA was 20%.
Conclusions
The combined assessment of important clinical factors enabled us to identify high‐risk infants set to derive optimal benefit from health guidance provided to the parent or caregiver of the child or infant at WCVs.
Subjects
MeSH terms (MEDLINE)
Author keywords
Authors and institutions
- Department of Allergy, Allergy and Immunology Center, Aichi Children's Health and Medical Center, Aichi, Japan.
- Nagoya City Public Health Research Institute, Aichi, Japan.
- Department of Pediatrics, National Hospital Organization Nagoya Medical Center, Aichi, Japan.
- Department of Pediatrics, Nagoya City University West Medical Center, Aichi, Japan.
- Department of Nursing, Faculty of Nursing, Kinjo Gakuin University, Aichi, Japan.
- School of Nutritional Sciences, Nagoya University of Arts and Sciences, Aichi, Japan.
ORCID profiles: Shiro Sugiura, Masaki Futamura, Chikae Yamaguchi
Cite
APA
Sugiura, S., Hiramitsu, Y., Futamura, M., Kamioka, N., Yamaguchi, C., Umemura, H., Kondo, Y., & Ito, K. (2023). Clinical risk factors at 3 months of age for the development of bronchial asthma at 36 months of age. Pediatrics International. https://doi.org/10.1111/ped.15530
Vancouver
Sugiura S, Hiramitsu Y, Futamura M, Kamioka N, Yamaguchi C, Umemura H, et al. Clinical risk factors at 3 months of age for the development of bronchial asthma at 36 months of age. Pediatrics International. 2023. doi:10.1111/ped.15530
BibTeX
@article{Sugiura2023,
author = {Sugiura, Shiro and Hiramitsu, Yoshimichi and Futamura, Masaki and Kamioka, Naomi and Yamaguchi, Chikae and Umemura, Harue and Kondo, Yasuto and Ito, Komei},
title = {Clinical risk factors at 3 months of age for the development of bronchial asthma at 36 months of age},
journal = {Pediatrics International},
year = {2023},
doi = {10.1111/ped.15530}
}
EUVIMED